top of page

Clinical Trials

Trials are being held to evaluate the efficacy of HSCT for MS. 

StarMS research study

The StarMS trial aims to compare the efficacy and safety profile of Autologous Haematopoietic Stem Cell Transplantation (aHSCT) vs 4 ‘highly effective’ Disease Modifying Therapies (DMTs) – Ocrelizumab, Alemtuzumab, Cladribine and Ofatumumab.

Read More
bottom of page